Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.210
+0.040 (1.84%)
At close: Oct 19, 2026

Coegin Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
63110785197228
Market Cap Growth
-64.43%40.73%55.23%-47.61%-57.65%-
Enterprise Value
61103694492197
Last Close Price
2.174.443.855.3813.4636.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
143.291398.18----
PB Ratio
10.2523.293.117.494.5911.35
P/TBV Ratio
14.4070.624.09-10.4611.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
137.561304.89----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.41-1.67-0.78-0.82-0.18-1.28
Net Debt / EBITDA Ratio
0.130.460.970.220.120.94
Net Debt / FCF Ratio
0.110.480.830.250.101.19
Asset Turnover
0.030.00----
Quick Ratio
1.590.9911.610.710.842.95
Current Ratio
2.771.1611.710.720.852.96
Return on Equity (ROE)
-199.51%-136.64%-148.58%-201.53%-171.54%-147.59%
Return on Assets (ROA)
-103.96%-63.31%-68.67%-77.82%-72.78%-68.67%
Return on Capital Employed (ROCE)
-356.90%-431.20%-92.40%-412.00%-165.10%-135.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-34.98%-18.56%-30.30%-55.34%-36.52%-11.91%
FCF Yield
-35.14%-15.09%-30.12%-43.58%-39.61%-9.43%
Buyback Yield / Dilution
-9.46%-31.30%-105.53%-34.42%-15.36%-354.98%